CA9 and melanoma: Immuno-isolation with the anti-CAIX-antibody improved the detection of the melanoma-specific BRAFV600E gene compared to the generic EV precipitation, indicating the enrichment of tumor-derived sEVs carrying the mutation (Figure 6).